 | • レポートコード：MRC2305A070 • 出版社/出版日：Transparency Market Research / 2023年3月14日 • レポート形態：英文、PDF、157ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥869,250 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,319,250 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,769,250 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の当調査レポートによると、世界の肺動脈弁置換市場規模が、2023年の10億ドルから2031年に16億ドルとなり、予測期間中に年平均4.9%で成長すると推測されています。本レポートは、肺動脈弁置換の世界市場について徹底的に分析・調査を行い、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、主要インサイト、弁種類別（機械弁、生体弁）分析、用途別（肺動脈弁狭窄症、肺動脈閉鎖症、その他）分析、エンドユーザー別（病院、外来手術センター、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況など、以下の項目を整理しています。また、Boston Scientific、Edwards Lifesciences、Medtronic、St. Jude Medical、Abbott、Cryolife、LivaNova, Inc.、4C Medical Technologies, Inc.など、主要企業情報を含んでいます。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・主要インサイト ・世界の肺動脈弁置換市場規模：弁種類別 - 機械弁の市場規模 - 生体弁の市場規模 ・世界の肺動脈弁置換市場規模：用途別 - 肺動脈弁狭窄症における市場規模 - 肺動脈閉鎖症における市場規模 - その他用途における市場規模 ・世界の肺動脈弁置換市場規模：エンドユーザー別 - 病院における市場規模 - 外来手術センターにおける市場規模 - その他エンドユーザーにおける市場規模 ・世界の肺動脈弁置換市場規模：地域別 - 北米の肺動脈弁置換市場規模 - ヨーロッパの肺動脈弁置換市場規模 - アジア太平洋の肺動脈弁置換市場規模 - 中南米の肺動脈弁置換市場規模 - 中東・アフリカの肺動脈弁置換市場規模 ・競争状況 |
Pulmonary Valve Replacement Market – Scope of Report
TMR’s report on the global pulmonary valve replacement market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global pulmonary valve replacement market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global pulmonary valve replacement market from 2023 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the pulmonary valve replacement market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global pulmonary valve replacement market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global pulmonary valve replacement market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global pulmonary valve replacement market.
The report delves into the competitive landscape of the global pulmonary valve replacement market. Key players operating in the global pulmonary valve replacement market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global pulmonary valve replacement market profiled in this report.
Key Questions Answered in Global Pulmonary Valve Replacement Market Report
• What is the sales/revenue generated by pulmonary valve replacement across all regions during the forecast period?
• What are the opportunities in the global pulmonary valve replacement market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2031?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?
Pulmonary Valve Replacement Market – Research Objectives and Research Approach
The comprehensive report on the global pulmonary valve replacement market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global pulmonary valve replacement market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global pulmonary valve replacement market.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Pulmonary Valve Replacement Market
4. Market Overview
4.1. Introduction
4.1.1. Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Pulmonary Valve Replacement Market Analysis and Forecast, 2017-2031
4.4.1. Market Revenue Projections (US$ Bn)
5. Key Insights
5.1. Key Industry Events
5.2. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
5.3. Pricing Analysis of Different Mechanical Valves
5.4. Pulmonary Diseases Prevalence Overview
6. Global Pulmonary Valve Replacement Market Analysis and Forecast, by Valve Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Valve Type, 2017-2031
6.3.1. Mechanical Valve
6.3.2. Biological Valve
6.3.2.1. Donor Valve
6.3.2.2. Tissue Valve
6.4. Market Attractiveness Analysis, by Valve Type
7. Global Pulmonary Valve Replacement Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2017-2031
7.3.1. Pulmonary Valve Stenosis
7.3.2. Pulmonary Atresia
7.3.3. Others
7.4. Market Attractiveness Analysis, by Application
8. Global Pulmonary Valve Replacement Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017-2031
8.3.1. Hospitals
8.3.2. Ambulatory Surgical Centers
8.3.3. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Pulmonary Valve Replacement Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Pulmonary Valve Replacement Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Valve Type, 2017-2031
10.2.1. Mechanical Valve
10.2.2. Biological Valve
10.2.2.1. Donor Valve
10.2.2.2. Tissue Valve
10.3. Market Value Forecast, by Application, 2017-2031
10.3.1. Pulmonary Valve Stenosis
10.3.2. Pulmonary Atresia
10.3.3. Others
10.4. Market Value Forecast, by End-user, 2017-2031
10.4.1. Hospitals
10.4.2. Ambulatory Surgical Centers
10.4.3. Others
10.5. Market Value Forecast, by Country, 2017-2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Valve Type
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Pulmonary Valve Replacement Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Valve Type, 2017-2031
11.2.1. Mechanical Valve
11.2.2. Biological Valve
11.2.2.1. Donor Valve
11.2.2.2. Tissue Valve
11.3. Market Value Forecast, by Application, 2017-2031
11.3.1. Pulmonary Valve Stenosis
11.3.2. Pulmonary Atresia
11.3.3. Others
11.4. Market Value Forecast, by End-user, 2017-2031
11.4.1. Hospitals
11.4.2. Ambulatory Surgical Centers
11.4.3. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Valve Type
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Pulmonary Valve Replacement Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Valve Type, 2017-2031
12.2.1. Mechanical Valve
12.2.2. Biological Valve
12.2.2.1. Donor Valve
12.2.2.2. Tissue Valve
12.3. Market Value Forecast, by Application, 2017-2031
12.3.1. Pulmonary Valve Stenosis
12.3.2. Pulmonary Atresia
12.3.3. Others
12.4. Market Value Forecast, by End-user, 2017-2031
12.4.1. Hospitals
12.4.2. Ambulatory Surgical Centers
12.4.3. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Valve Type
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Pulmonary Valve Replacement Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Valve Type, 2017-2031
13.2.1. Mechanical Valve
13.2.2. Biological Valve
13.2.2.1. Donor Valve
13.2.2.2. Tissue Valve
13.3. Market Value Forecast, by Application, 2017-2031
13.3.1. Pulmonary Valve Stenosis
13.3.2. Pulmonary Atresia
13.3.3. Others
13.4. Market Value Forecast, by End-user, 2017-2031
13.4.1. Hospitals
13.4.2. Ambulatory Surgical Centers
13.4.3. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Valve Type
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Pulmonary Valve Replacement Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Valve Type, 2017-2031
14.2.1. Mechanical Valve
14.2.2. Biological Valve
14.2.2.1. Donor Valve
14.2.2.2. Tissue Valve
14.3. Market Value Forecast, by Application, 2017-2031
14.3.1. Pulmonary Valve Stenosis
14.3.2. Pulmonary Atresia
14.3.3. Others
14.4. Market Value Forecast, by End-user, 2017-2031
14.4.1. Hospitals
14.4.2. Ambulatory Surgical Centers
14.4.3. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Valve Type
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2022
15.3. Company Profiles
15.3.1. Boston Scientific
15.3.1.1. Company Overview
15.3.1.2. Valve Type Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Strategic Overview
15.3.2. Edwards Lifesciences
15.3.2.1. Company Overview
15.3.2.2. Valve Type Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Strategic Overview
15.3.3. Medtronic
15.3.3.1. Company Overview
15.3.3.2. Valve Type Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Strategic Overview
15.3.4. St. Jude Medical
15.3.4.1. Company Overview
15.3.4.2. Valve Type Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Strategic Overview
15.3.5. Abbott
15.3.5.1. Company Overview
15.3.5.2. Valve Type Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Strategic Overview
15.3.6. Cryolife
15.3.6.1. Company Overview
15.3.6.2. Valve Type Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Strategic Overview
15.3.7. LivaNova, Inc.
15.3.7.1. Company Overview
15.3.7.2. Valve Type Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Strategic Overview
15.3.8. 4C Medical Technologies, Inc.
15.3.8.1. Company Overview
15.3.8.2. Valve Type Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Strategic Overview